🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT03383016
Active, not recruiting Observational

Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)

NCT03383016 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2013-06-20
Last updated
2025-12-30

Condition(s) studied

EpidemiologyProstate Cancer

Investigational drug(s) / intervention(s)

Lifestyle questionnairesProstate Biopsy

Prostate Biopsy: Possible follow-up by an urologist at 1 year and 2 years after recruitment. After 2 years, proposal for a 2-year end-of-study prostate biopsy to assess the presence or absence of prostate cancer.

Study summary

The risk of prostate cancer is associated with lifestyle habits, such as diet and physical activity. Indeed, results of numerous studies suggest links between obesity, diabetes, inflammation and androgen and estrogen metabolism in the pathogenesis of prostate cancer.

The goal of BIOCaPPE study (Biomarkers and Prostate Cancer/ Prevention and Environment) is to identify biomarkers of prostate cancer risk that are potentially modifiable by environmental exposures (e.g. diet and physical activity).

A selection of few of the most promising biological markers will be evaluated in a cohort of more than 2000 men at high-risk of prostate cancer.

Such biomarkers would provide a practical approach to identify men at high risk of prostate cancer who could benefit from interventions aiming at reducing their risk. The biomarkers would also be useful to monitor the efficacy of the interventions on patient's lifestyle.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Group 1: A first negative prostate biopsy within 6 months * Group 2: serum-PSA level between 2.5-10 ng/mL and no prior prostate biopsy Exclusion Criteria: * Prostate cancer * Positive result for transurethral prostatic resection

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montreal Quebec
McGill University Health Center Montreal Quebec
CHU de Quebec- Université Laval Québec Quebec
Centre de recherche du Centre hospitalier universitaire de Sherbrooke Sherbrooke Quebec

More CHU de Quebec-Universite Laval trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03383016 on ClinicalTrials.gov ↗ ← All trials in Canada